BRACO19 hydrochloride
SIGMA/SML0560 - ≥96% (HPLC)
Synonym: N,N′-(9-(4-(Dimethylamino)phenylamino)acridine-3,6-diyl)bis(3-(pyrrolidin-1-yl)propanamide) hydrochloride
CAS Number: 1177798-88-7
Empirical Formula (Hill Notation): C35H43N7O2 · xHCl
Molecular Weight: 593.76 (free base basis)
MDL Number: MFCD23380200
Linear Formula: C35H43N7O2 · xHCl
Product Type: Chemical
| assay | ≥96% (HPLC) |
| color | yellow to brown |
| form | powder |
| InChI | 1S/C35H43N7O2.3ClH/c1-40( |
| InChI key | MJAPNWJRLLDPAB-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Cl.Cl.Cl.CN(C)c1ccc(Nc2c3 |
| solubility | H2O: 5 mg/mL, clear |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Application: | BRACO19 hydrochloride has been used to study the role of antiviral activity of G4-stabilizing agents in cells infected with latent human immunodeficiency virus -1 (HIV-1). |
| Biochem/physiol Actions: | BRACO19 is a telomerase inhibitor that stabilizes G-quadruplexes, targeting telomeric G-quadruplexes, inducing DNA damage and cell-cycle arrest. |
| Biochem/physiol Actions: | BRACO19 stabilizes G-quadruplexes; telomerase inhibitor. |
| Biochem/physiol Actions: | Telomerase is associated with tumor progression and is highly expressed in a number of tumors. BRACO19 is known to prevent the capping and catalytic action of telomerase and thus, might serve as an effective therapeutic approach for cancer treatment. BRACO19 establishes antiviral activity against HIV (human immunodeficiency virus). |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P330 + P331 + P310 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥96% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


